• USA: Alexion Reaches US$21 Million Settlement with SEC

    Boston-based pharmaceutical company Alexion Pharmaceuticals, Inc. said it will pay US$21.5 million to settle bribery and other violations of the US Foreign Corrupt Practices Act (FCPA) charges with the US Securities and Exchange Commission (SEC).

Subscribe to our weekly newsletter!

And get our latest investigations on organized crime and corruption delivered straight to your inbox.